Markets

How The Pieces Add Up: IYH Targets $175

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares U.S. Healthcare ETF (Symbol: IYH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $175.37 per unit.

With IYH trading at a recent price near $136.23 per unit, that means that analysts see 28.73% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of IYH's underlying holdings with notable upside to their analyst target prices are Novavax, Inc. (Symbol: NVAX), Acadia Pharmaceuticals Inc (Symbol: ACAD), and Halozyme Therapeutics Inc (Symbol: HALO). Although NVAX has traded at a recent price of $4.59/share, the average analyst target is 209.17% higher at $14.19/share. Similarly, ACAD has 154.76% upside from the recent share price of $18.89 if the average analyst target price of $48.12/share is reached, and analysts on average are expecting HALO to reach a target price of $20.00/share, which is 146.61% above the recent price of $8.11. Below is a twelve month price history chart comparing the stock performance of NVAX, ACAD, and HALO:

NVAX, ACAD, and HALO Relative Performance Chart

Below is a summary table of the current analyst target prices discussed above:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
iShares U.S. Healthcare ETF IYH $136.23 $175.37 28.73%
Novavax, Inc. NVAX $4.59 $14.19 209.17%
Acadia Pharmaceuticals Inc ACAD $18.89 $48.12 154.76%
Halozyme Therapeutics Inc HALO $8.11 $20.00 146.61%

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

10 ETFs With Most Upside To Analyst Targets »

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ACAD HALO IYH NVAX

Other Topics

ETFs

Latest Markets Videos

    BNK Invest

    BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.

    Learn More